Skip to main navigation
BillionToOne Inc. corporate website BillionToOne Inc. corporate website
Products
OncologyPrenatal
Technology
TechnologyPublications
Careers
Working with usOpen Positions
Company
Mission, Vision, ValuesLeadership & BoardCompany Milestones
News & Media
Press ReleasesEventsMedia CoverageSocial Media
Investors
OverviewNews & EventsStock InformationCorporate GovernanceFinancial InformationIR Resources

Documents & Charters

Investor Menu
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
  • Corporate Governance
    • Documents & Charters
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • IR Resources
    • Investor FAQs
    • Analyst Coverage
    • Email Alerts
    • Contact Us

Governance Documents

Amended and Restated Bylaws
Amended and Restated Certificate of Incorporation
Code of Conduct
Corporate Governance Guidelines

Committee Charters

Audit Committee Charter
Compensation Committee Charter
BillionToOne Inc. corporate website
We are ONE team, working
toward ONE goal – to detect
disease ONE molecule at a time.
CAP Accredited - College of American Pathologists Logo
  • LinkedIn
  • Twitter
What We Offer
  • Our Technology
  • Publications
  • Products
Explore
  • News & Media
  • Press Releases
  • Media Coverage
  • Events
  • Social Media
About Us
  • Careers
  • Patient Portal
  • IT Security Compliance
Contact
  • Contact Information
  • Privacy Policy
  • Notice of Privacy Practices
  • Accessibility Statement
  • TERMS OF USE
ACCREDITATIONS UNION CITY:
  • CA: CDF-00353741
  • CAP: 8643216
  • CLIA: 05D2167800
  • MD: 2999
  • PA: 37021
  • RI: LCO01671
  • DC: HFD-OS29
  • NYSDOH: 9828
ACCREDITATIONS MENLO PARK:
  • CA: CDF-90008579
  • CAP: 9568790
  • CLIA: 05D2275351
  • MD: 3855
  • PA: 40795
  • RI: LCO01700
  • DC: HFD-OS43
  • PATENT MARKINGS
© 2026 BillionToOne Inc.
All rights reserved.